Streetbeat News

Products Services

INDP

Indaptus Therapeutics, Inc. (NASDAQ:INDP) announced that it will present new data on its Decoy platform at the AACR Annual Meeting, demonstrating the platform's ability to activate multiple immune cell types for anti-tumor responses. The data, supporting the efficacy of Decoy10 and Decoy20 for cancer treatment, will be detailed in a poster session by Dr. Michael Newman. The findings are significant for advancing the treatment of solid tumors with the Decoy platform.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 12:41 pm

ESPR

MASI

MLGO

MicroAlgo Inc. (MLGO) shares surged 102% following the announcement of a new deep clustering algorithm. Masmi (MASI) shares rose 15% after the company considered separating its consumer business. Esperion (ESPR) shares increased 26% after FDA approval for NEXLETOL and NEXLIZET for heart attack and cardiovascular procedure prevention.

Portfolio Pulse from ryanfaloona@benzinga.com

March 25, 2024 | 12:40 pm

OTLY

Oatly Group AB (OTLY) has announced a new distribution arrangement with Virgin Voyages, making Oatly Barista Edition the official oatmilk for all guests aboard Virgin Voyages' fleet. This partnership allows Oatly to expand its presence and reach over 2,700 guests per trip, aligning with its mission to provide a sustainable alternative to cow's milk. Oatly Barista Edition is designed to foam easily and not separate in hot or cold beverages, offering a delicious complement to coffee and tea without sacrificing taste or performance. The product also boasts a 46% lower climate impact than cow's milk in the U.S.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 12:38 pm

LCFY

YEXT

Locafy Limited, in collaboration with Yext, announced the launch of Hotfrog Proximity Page, a new application designed to enhance online presences and drive website traffic for businesses. This application integrates Yext's digital presence platform with Locafy's SEO technology, allowing for the creation of dynamic, SEO-optimized landing pages. The application is currently being piloted with a broader rollout expected in 2024. Locafy CEO Gavin Burnett highlighted the application's potential to improve online visibility and consistency across platforms.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 12:37 pm

LUCY

Innovative Eyewear Inc. (NASDAQ: LUCY) reported a 75% increase in FY23 revenue, reaching $1,152,479 from $659,788 YoY. Q4 2023 sales hit a record $615,754, marking the fourth consecutive quarter of growth. Despite this, the net loss widened to $6,663,428 from $5,681,833 due to operational scale-up. The company attributes growth to direct-to-consumer and Amazon sales, and anticipates further growth with the launch of new smart eyewear lines in 2024.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 12:36 pm

MARA

Marathon Digital Holdings, Inc. (NASDAQ:MARA) has launched MARAFW and MARA UCB 2100, firmware and a control board designed to enhance Bitcoin mining rigs' performance, efficiency, and stability. These products, developed as part of Marathon's vertical tech stack, are now available to the broader Bitcoin mining community after successful deployment across Marathon's fleet of over 200,000 rigs and sales to enterprise clients. The technology aims to optimize mining operations, offering features like increased hash rate, thermal protection, and compatibility with various mining pools.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 12:32 pm

ABBV

LABP

AbbVie Inc. is set to acquire Landos Biopharma for approximately $137.5 million, or $20.42 per share in cash, with an additional contingent value right of up to $11.14 per share, subject to clinical development milestones. This acquisition aims to advance the clinical development of NX-13, a novel oral treatment for autoimmune diseases such as ulcerative colitis and Crohn's disease. The transaction is expected to close in the second quarter of 2024, pending customary closing conditions and approval by Landos' stockholders.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 12:32 pm

STIM

NeuroStar Advanced Therapy has been granted FDA clearance to be used as a first-line add-on treatment for adolescents suffering from depression. This marks a significant milestone as it becomes the first therapy of its kind to receive such approval, potentially opening new avenues for treatment in younger populations.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 12:31 pm

GPRE

Green Plains Inc. has initiated the commissioning of a demonstration facility in York, Nebraska, integrating Fluid Quip Technologies' MSC with Shell Fiber Conversion Technology. This facility aims to enhance the production of renewable corn oil, cellulosic sugars for low-carbon fuels, and Ultra-High Protein feed ingredients. The collaboration between Green Plains and Shell represents a significant step towards transforming the grain processing and biofuels industry. The successful demonstration could lead to commercial deployment, with Green Plains handling protein product distribution and Shell managing low-carbon feedstocks.

Portfolio Pulse from Benzinga Newsdesk

March 25, 2024 | 12:24 pm

CMG

CNM

MU

NVDA

SHAK

Wall Street's most accurate analysts have made new stock picks, highlighting potential upsides and downsides in companies like Micron Technology, NVIDIA, Shake Shack, Core & Main, and Chipotle Mexican Grill. These picks are based on recent company performances and market trends, with analysts from firms like Oppenheimer, Truist Securities, Wedbush, Deutsche Bank, and Wells Fargo providing insights.

Portfolio Pulse from Avi Kapoor

March 25, 2024 | 12:23 pm